9 The peer companies and their ratios noted in the figure include Abbvie(1.25), Amgen(1.32), AstraZeneca(0.36), Biogen(0.71), Bristol-Myers(0.86), Eli Lilly(0.43), Gilead(0.70), GSK(0.54), JNJ(0.76), Merck(0.38), Novartis(1.25), Novo Nordisk(1.41), Pfizer(0.71), Roche(0.86), and Sanofi(0.57) 10 Lilly announces new $15 billion share repurchase program and seventh consecutive 15% dividend increase
We have 165 employees, but we have about 40 of them that are on GLP-1 agonists for weight loss
Serious risks like pancreatitis are rare but require medical monitoring
So, meals are digested more slowly, which lowers the rise in blood sugar after a meal
For research only is a red flag because it means the product is not intended for personal medical use unless supplied in a legitimate research study through a legitimate research institute